Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Intelligent Synthetic Biology Center patents


Recent patent applications related to Intelligent Synthetic Biology Center. Intelligent Synthetic Biology Center is listed as an Agent/Assignee. Note: Intelligent Synthetic Biology Center may have other listings under different names/spellings. We're not affiliated with Intelligent Synthetic Biology Center, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Intelligent Synthetic Biology Center-related inventors


Anti-diabetic effects of gypenoside 75

The present invention relates to a composition for preventing, improving, or treating diabetes mellitus, and more specifically, relates to pharmaceutical, food, and feed compositions comprising gypenoside 75 or a pharmaceutically acceptable salt thereof. Additionally, the present invention relates to a method for preventing or treating diabetes mellitus using the composition.. ... Intelligent Synthetic Biology Center

Composition for preventing or treating cervical cancer including gypenoside lxxv

Provided are a pharmaceutical composition for preventing or treating cervical cancer including gypenoside lxxv or a pharmaceutically acceptable salt thereof as an active ingredient, a method of preventing or treating cervical cancer including administering the pharmaceutical composition to a subject excluding humans, a health functional food composition for preventing or improving cervical cancer including gypenoside lxxv as an active ingredient, and a feed composition for preventing or improving cervical cancer including gypenoside lxxv as an active ingredient.. . ... Intelligent Synthetic Biology Center

Anticancer adjuvant containing panaxadiol ginsenocide compound

The present invention relates to an anticancer adjuvant containing, as an active ingredient, protopanaxadiol (ppd) or a compound-k, which are types of panaxadiol ginsenoside compounds, and a pharmaceutical composition for treating cancer containing the anticancer adjuvant and an anticancer agent having mitochondria-mediated anticancer activity. The anticancer adjuvant containing the ppd or compound-k provided in the present invention as an active ingredient damages mitochondria in cancer cells, thereby aiding mitochondria-mediated anticancer activity, and thus can be widely used in safer treatment or alleviation of cancer using anticancer agents that exhibit mitochondria-mediated anticancer activity.. ... Intelligent Synthetic Biology Center

A method for screening regulator of mitochondrial fission

The present invention is directed to a method for screening a regulator of mitochondrial fission using a cell treated to a protopanaxadiol (ppd)-type ginsenoside compound, a composition therefor, and a kit comprising the composition. As the use of the method for screening the regulator of mitochondrial fission of the present invention enables effective discovery of a formulation capable of preventing, improving, or treating a mitochondria-related disease, the method will be widely used for the development of a therapeutic agent for the mitochondria-related disease.. ... Intelligent Synthetic Biology Center

Method of preparing cinnamaldehyde

Provided is a method of preparing cinnamaldehyde by using a recombinant microorganism.. . ... Intelligent Synthetic Biology Center

Porous structure with improved porosity, method for producing the porous structure, porous hierarchical structure and method for producing the porous hierarchical structure

A porous structure according to one embodiment of the present invention is constituted by a frame having a plurality of pores interconnected 3-dimensionally through a plurality of connecting passages. The plurality of pores defined by the frame are distributed in a closest packed state and are interconnected 3-dimensionally through a plurality of connecting passages in a symmetric structure, thus being effective in achieving a maximum porosity of the porous structure. ... Intelligent Synthetic Biology Center

Pharmaceutical composition for preventing or treating gleevec-resistant leukemia containing ginsenoside f1 or ginsenoside rg3 as an active ingredient

The present invention relates to a pharmaceutical composition for preventing or treating gleevec-resistant leukemia, containing, as an active ingredient, ginsenoside f1 or rg3 which exhibits a preventive or therapeutic effect on gleevec-resistant leukemia through enhancing cell killing activity of nk cells; a method for treating gleevec-resistant leukemia comprising a step of administering the pharmaceutical composition; and a food composition for preventing or ameliorating gleevec-resistant leukemia. Since the pharmaceutical composition of the present invention can effectively treat leukemia that exhibits resistance to conventional gleevec, the pharmaceutical composition can be widely used for effective leukemia treatment.. ... Intelligent Synthetic Biology Center

Composition for preventing or treating liver cancer containing ginsenoside f2

The present invention relates to a composition for preventing or treating liver cancer containing ginsenoside f2 as an active ingredient. Specifically, the composition according to the present invention kills liver cancer cells, specifically inhibits the formation of liver cancer, and reduces the expression of alanine aminotransferase (alt) or aspartate aminotransferase (ast), without affecting normal hepatocytes, and thus can be usefully used as a therapeutic agent for liver cancer.. ... Intelligent Synthetic Biology Center

Composition for enhancing immunity including ginsenoside f1 as an active ingredient

The present invention relates to composition for enhancing immunity, comprising ginsenoside f1 as an active ingredient. Specifically, the composition according to the present invention promotes degranulation activity and cell-killing activity of natural killer cells, and increases expressions of cell-killing factors, thereby being effectively used as an immune enhancer.. ... Intelligent Synthetic Biology Center

Method for screening activator of mitochondrial activity

The present invention relates to a method for screening an activator of mitochondrial activity by using gypenoside-treated cells, to a composition for screening an activator of mitochondrial activity, comprising the gypenoside, and to a kit comprising the composition. By using the method for screening an activator of mitochondrial activity of the present invention, it is possible to effectively discover a preparation which can substantially promote the mitochondrial activity, and thus the method is expected to be widely used in developing a therapeutic agent for diseases caused by mitochondrial activity inhibition.. ... Intelligent Synthetic Biology Center

Method for producing a minor ginsenoside using a ginsenoside glycosidase

Provided are a method of producing minor ginsenosides using a ginsenoside glycosidase protein derived from a microbacterium sp. (microbacterium testaceum) microorganism, and a composition including the protein for conversion into minor ginsenosides. ... Intelligent Synthetic Biology Center

A novel method for glycosylation of ginsenoside using a glycosyltransferase derived from panax ginseng

The present invention relates to a uridine diphosphate (udp)-glycosyltransferase protein which has glycosylation activity for a hydroxyl group at the c-20 position of a protopanaxadiol (ppd)- or protopanaxatriol (ppt)-type ginsenoside, and a method for glycosylation of udp using the same.. . ... Intelligent Synthetic Biology Center

Composition containing ginsenoside f1 for removing amyloid plaques

Provided are a food composition and a feed composition for removing amyloid plaques, each composition including ginsenoside f1, in which ginsenoside f1 is effective for removing amyloid plaques in the hippocampal area of the brain.. . ... Intelligent Synthetic Biology Center








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Intelligent Synthetic Biology Center in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Intelligent Synthetic Biology Center with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###